8-KFiled Aug 23, 8:00 PM ET

Stark Novus Financial Enters Omnibus Loan Amendment with Foxpoint Borrowers

$NRDE · Stark Novus Financial Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Stark Novus Financial Enters Omnibus Loan Amendment with Foxpoint Borrowers

What Happened
On August 18, 2026, Stark Novus Financial Inc. (the Company), acting as one of the lenders, entered into an Omnibus Amendment to Financing Documents with six Foxpoint Florida borrower entities and 4445 W. Vine, LLC (collectively, the Borrowers), guarantor James Neumann, and the other lender parties. The amendment defers monthly interest installments for June 1 through September 1, 2026 to the closing date of a planned sale of certain billboard and related assets in Central Florida (the “Orlando Sale”), and ties repayment priority to the net proceeds of that sale.

Key Details

  • Agreement date: August 18, 2026. Borrowers include Foxpoint Florida, LLC; Foxpoint Florida II, III, IV, V, LLCs; and 4445 W. Vine, LLC. Guarantor: James Neumann.
  • Interest deferral: Monthly interest installments due June 1–September 1, 2026 are deferred to the closing of the Orlando Sale.
  • Letter of intent: Guarantor required to execute an LOI for the Orlando Sale on or before August 19, 2026 (Company orally extended to August 25, 2026).
  • Application of proceeds: Net proceeds of the Orlando Sale will be applied first to pay in full all amounts owing to the lenders.
  • Additional collateral: Guarantor will pledge a billboard asset in Bridgeton, Missouri to secure any shortfall after the Orlando Sale proceeds; a Bakersfield, California billboard will be pledged under the Foxpoint Florida loan documents upon certain defaults.
  • Disclosure: The Company expects to file the Omnibus Amendment as an exhibit to its Form 10-Q for the quarter ended September 30, 2026.

Why It Matters
This amendment changes the timing and priority of repayment for the affected loans by deferring several months of interest payments and making repayment dependent on the proceeds of a specified asset sale. For investors, the filing shows the Company is negotiating borrower relief tied to asset-sale proceeds and receiving additional collateral pledges, but it does not disclose dollar amounts or confirm the Orlando Sale’s closing. The full Omnibus Amendment (to be filed with the upcoming 10-Q) will provide additional detail on the financial exposure and protections for the lenders.